相似文献
1
Walking Training of a Vascular Sports Group.
Dtsch Arztebl Int. 2020 Oct 2;117(40):677. doi: 10.3238/arztebl.2020.0677b.
2
; GENDER-ASSOCIATED EFFECTS OF SEROLOGICAL MARKERS OF BLOOD GROUPS ON THE DEVELOPMENT OF ATTENTION FUNCTION OF YOUNG ADOLESCENT ATHLETES.
Georgian Med News. 2020 Jul-Aug(304-305):103-111.
3
Walking, bicycling, and sports in postmenopausal breast cancer survivors--results from a German patient cohort study.
Psychooncology. 2013 Jun;22(6):1291-8. doi: 10.1002/pon.3134. Epub 2012 Jul 16.
4
Effects of Participation in Sports Programs on Walking Ability and Endurance Over Time in Children With Cerebral Palsy.
Am J Phys Med Rehabil. 2017 Dec;96(12):843-851. doi: 10.1097/PHM.0000000000000767.
5
Walking and sports participation and mortality from coronary heart disease and stroke.
J Am Coll Cardiol. 2005 Nov 1;46(9):1761-7. doi: 10.1016/j.jacc.2005.07.038. Epub 2005 Oct 10.
6
Effects of the Integration of Dynamic Weight Shifting Training Into Treadmill Training on Walking Function of Children with Cerebral Palsy: A Randomized Controlled Study.
Am J Phys Med Rehabil. 2017 Nov;96(11):765-772. doi: 10.1097/PHM.0000000000000776.
7
8
Adolescents who take part in team sports, or who actively commute to school, are less likely to be obese.
Evid Based Nurs. 2013 Jul;16(3):87-8. doi: 10.1136/eb-2012-101048. Epub 2012 Dec 12.
9
RESEARCH OF PECULIARITIES OF DEVELOPMENT OF TIME PERCEPTION FUNCTION IN 13-15 YEAR-OLD ATHLETES WITH DIFFERENT BLOOD GROUPS.
Georgian Med News. 2020 Oct(307):142-149.
10
Training for a walkathon.
Diabetes Self Manag. 2007 Jul-Aug;24(4):56-8, 60-2, 65.
本文引用的文献
1
Intermittent Claudication and Asymptomatic Peripheral Arterial Disease.
Dtsch Arztebl Int. 2020 Mar 13;117(11):188-193. doi: 10.3238/arztebl.2020.0188.
2
[Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Dtsch Med Wochenschr. 1987 May 29;112(22):873-8. doi: 10.1055/s-2008-1068157.
3
[Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Wien Med Wochenschr. 1989 Sep 15;139(17):396-401.
4
[Hemodilution in peripheral arterial occlusive disease].
Vasa Suppl. 1988;26:113-5.
Zotero 插件